Tang Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$809K Buy
+50,152
New +$809K 0.04% 170